Introducing new cost effective treatments into the NHS. Surfactant treatment for premature babies: who cares enough to pay?
Halliday
H L
HL
Department of Child Health, Queen's University of Belfast.
D002985:Clinical Protocols / Q000592:standards*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000453:epidemiology; D011663:Pulmonary Surfactants / Q000191:economics / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy; D013222:State Medicine / Q000191:economics / Q000592:standards*; D006113:United Kingdom / Q000453:epidemiology